Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
暂无分享,去创建一个
R. Adelung | O. Janssen | S. Sebens | M. Synowitz | F. Schütt | R. Lucius | J. Held-Feindt | J. Haag | C. Kubelt | Margarethe Hauck | Dana Hellmold | S. Beckinger | T. Daunke